Deltarasin --- KRAS-PDEδ Inhibitor

Overview
Catalog #	bs-60218c-2-mg-solid
Product Name	Deltarasin --- KRAS-PDEδ Inhibitor
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 603.75 Formula: C40 H37 N5 O CAS Number: 1440898-61-2 InChi Key: LTZKEDSUXKTTTC-KXQOOQHDSA-N InChi: InChI=1S/C40H37N5O/c1-3-11-29(12-4-1)27-44-36-17-9-7-15-34(36)42-39(44)32-19-21-33(22-20-32)46-28-38(30-23-25-41-26-24-30)45-37-18-10-8-16-35(37)43-40(45)31-13-5-2-6-14-31/h1-22,30,38,41H,23-28H2/t38-/m1/s1 Smiles: C(C1C=CC=CC=1)N1C(=NC2C=CC=CC1=2)C1C=CC(=CC=1)OC[C@H](C1CCNCC1)N1C(=NC2C=CC=CC1=2)C1C=CC=CC=1 Purity: 98.0 Solubility: DMSO up to 100 mM Appearance: Solid Power. Shelf Life: 1.0 years
Description	Deltarasin is the potent and selective small molecular inhibitor of KRAS-PDEδ interaction, selectively binds to the prenyl-binding pocket of PDEδ with 38 nM affinity. It can inhibit oncogenic RAS signaling and suppress in vitro and in vivo proliferation of human pancreatic ductal adenocarcinoma cells that are dependent on oncogenic KRAS. Correct localization and signaling by farnesylated KRAS is regulated by the prenyl-binding protein PDEδ, which sustains the spatial organization of KRAS by facilitating its diffusion in the cytoplasm. Deltarasin provides a novel opportunity to suppress oncogenic RAS signaling by altering its localization to endomembranes, and may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic RAS.